Goshen Center for Cancer Care IU Health SC

Indianapolis, Indiana 46202

0 studies enrolling now · 2 studies all time

What they study most

Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors, Non-Small Cell Lung Cancer

Studies at this site

• Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC) — Completed
• Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) — Completed